Haleon plc (H6D.F)
| Previous Close | 7.50 |
| Open | 7.45 |
| Bid | 0.00 x N/A |
| Ask | 8.05 x N/A |
| Day's Range | 7.45 - 7.45 |
| 52 Week Range | 6.95 - 8.40 |
| Volume | |
| Avg. Volume | 23 |
| Market Cap | 35.158B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 28.65 |
| EPS (TTM) | 0.26 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.20 (2.61%) |
| Ex-Dividend Date | Mar 14, 2024 |
| 1y Target Est | N/A |
- Reuters
UPDATE 2-Sensodyne-maker Haleon posts tepid sales as demand for some products cool off
Consumer healthcare company Haleon reported first-quarter revenue slightly below market estimates on Wednesday, as volumes declined due to retailer destocking in U.S. and cooling demand for some of its medicines after a surge last year. The maker of popular household products such as Sensodyne toothpaste and pain-reliever Panadol, had earlier said that the first three months of 2024 would be impacted by a softer cold and flu season and a slowdown in painkiller Advil's sales in Canada, following a surge in demand last year. Demand for medicines such as Contac and Fenbid, which benefited from pent-up demand in China last year after lockdown restrictions were lifted, have also cooled, impacting Haleon's quarterly sales growth.
ReutersSensodyne-maker Haleon posts tepid sales as demand for some products cool off
The maker of popular household products such as Sensodyne toothpaste and pain-reliever Panadol, had earlier said that the first three months of 2024 would be impacted by a softer cold and flu season and a slowdown in painkiller Advil's sales in Canada, following a surge in demand last year. Demand for medicines such as Contac and Fenbid, which benefited from pent-up demand in China last year after lockdown restrictions were lifted, have also cooled, impacting Haleon's quarterly sales growth. On a reported basis, revenue was down 2.2% on last year.
PA Media: MoneySensodyne maker Haleon to shut UK factory with loss of 435 jobs
The consumer healthcare group is aiming to close the site on a phased basis over the next two years.
